Search Results - "Frizzell, B.A."

Refine Results
  1. 1
  2. 2

    Evaluating Baseline Socioeconomic Factors and Ability for Self-Care in Patients with Head and Neck Cancer: Secondary Analysis of a Prospective Pilot Trial by Nguyen, N.T., Frizzell, B.A., Burnett, L., Winkfield, K.M., Hughes, R.T.

    “…Socioeconomic barriers are associated with delayed diagnoses, adherence to treatment, and survival for patients with head and neck cancer. Few studies have…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Dosimetric Predictors of Clinician-rated and Patient-reported Radiation Dermatitis in Head and Neck Cancer: Exploratory Analysis of a Prospective Pilot Study by Hughes, R.T., Levine, B., Frizzell, B.A., Porosnicu, M., Lycan, T., Winkfield, K.M.

    “…There are no well-established dosimetric predictors of clinician-rated acute radiation dermatitis (ARD) in head and neck (HN) radiotherapy (RT). Data regarding…”
    Get full text
    Journal Article
  5. 5

    Feasibility of a Keratin-Based Topical Cream for Radiation Dermatitis in Patients with Head and Neck Cancer: Results of a Randomized Pilot Study by Hughes, R.T., Levine, B., Greven, K.M., Frizzell, B.A., Porosnicu, M., Lycan, T., Burnett, L., Winkfield, K.M.

    “…Acute radiation dermatitis (RD) is a frequent toxicity associated with radiotherapy (RT) for head and neck cancer (HNC). KeraStat Cream (KC), an emulsion-based…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Creation of Novel Inexpensive Low Artifact Brachytherapy Contrast Markers Compatible with CT and MRI by Farris, M., Lackey, C., Razavian, N., Lipford, M., Snavely, A.C., Glynn, S.E., Marshall, T.G., Dolesh, W., McKee, M.M., Ververs, J.D., Munley, M., Hughes, R.T., Frizzell, B.A., Brown, D., Black, P.J.

    “…Current interstitial brachytherapy needles utilize radio-opaque markers that are expensive, largely MR incompatible, and/or create significant artifact on…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Short-Course Palliative Radiotherapy Combined With Immunotherapy for Recurrent/Advanced/Metastatic Head and Neck Cancer by Iyer, A., Steber, C., Porosnicu, M., Lycan, T., Johnson, A.G., Frizzell, B.A., Greven, K.M., Hughes, R.T.

    “…To evaluate tumor response rates in patients treated with a combination of palliative short-course radiotherapy (SCRT) and immune checkpoint inhibitor…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Impact of Treatment Timing on Disease Outcomes in Patients Treated With Definitive Concurrent Chemoradiation for Head and Neck Cancer by Steber, C., Russell, G., Rush, M.C., Shenker, R.F., Frizzell, B.A., Greven, K.M., Hughes, R.T.

    “…The ideal timing for the initiation of chemotherapy and radiation therapy (RT) in the use of definitive chemoradiation (CRT) for patients with head and neck…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20